Thermo Fisher Scientific Inc. announced the grand opening of its Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, California. This innovative 6,000-square-foot facility is specifically designed to accelerate the development and commercialization of cell therapies, supporting biotech, biopharma, and translational customers.
The ATxCC enables cell therapy developers to leverage Thermo Fisher’s extensive product and technology portfolio, along with its deep process optimization knowledge, to create comprehensive, end-to-end manufacturing workflows. This support is crucial for scaling operations to achieve clinical and commercial success.
This new center is part of Thermo Fisher’s broader commitment to advancing life sciences, with existing collaboration centers in Singapore and Korea, and an expanded footprint in Philadelphia expected later this year. The ATxCC will provide essential resources and support for customers transitioning to Current Good Manufacturing Practices (cGMP manufacturing), helping to navigate go-to-market obstacles.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.